Evidence map›Paper›PMID 39082882›Full record

ArticleAntimicrobial agents and chemotherapy2024

Efficacy assessment of miltefosine and curcumin against

Soon-Ok Lee, Ki Back Chu, Keon-Woong Yoon, Gi-Deok Eom, Jie Mao, Hyeryon Lee, Joo Hwan No, Jin Ho Song, Sung-Jong Hong, Sung Soo Kim and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Soon-Ok Lee *Department of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Ki Back Chu *Department of Parasitology, Inje University College of Medicine, Busan, Republic of Korea.ORCID 0000-0002-2126-3366
Keon-Woong YoonDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Gi-Deok EomDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Jie MaoDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Hyeryon LeeHost-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam, Republic of Korea.
Joo Hwan NoHost-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam, Republic of Korea.
Jin Ho SongDepartment Pharmacology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Sung-Jong HongConvergence Research Center for Insect Vectors, Incheon National University, Incheon, Republic of Korea.
Sung Soo KimMedical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Fu-Shi QuanDepartment of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.ORCID 0000-0003-0419-9339

Funding

National Research Foundation of Korea (NRF) NRF2018R1A6A1A03025124National Research Foundation of Korea (NRF) NRF2022R1A2C1012199
6 · The paper itself

Abstract

Praziquantel (PZQ) is currently the only approved drug for treating clonorchiasis, but its poor efficacy against

Indexed as

AnthelminticsClonorchiasisClonorchis sinensisCurcuminPhosphorylcholinePraziquantelAnimalsCricetinaeLarvaMaleMesocricetusMetacercariaeAnthelminticsCurcuminmiltefosinePhosphorylcholinePraziquantelClonorchis sinensiscurcuminmetacercariamiltefosinenewly excysted larva

Identifiers

PMID39082882
PMCPMC11373209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.